Terms: = Breast cancer AND ACSL3, PRO2194, 2181, ENSG00000123983, O95573, FACL3, ACS3 AND Treatment
12 results:
1. Overall survival and associated factors in women with metastatic breast cancer treated with trastuzumab at a public referral institution.
Gonçalves DS; Santos AMRD; Costa SCVD; Costa RSD; Senna KMSE; Zimmermann IR
Rev Bras Epidemiol; 2023; 26():e230045. PubMed ID: 37878833
[TBL] [Abstract] [Full Text] [Related]
2. Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis.
Xie Y; Wang B; Zhao Y; Tao Z; Wang Y; Chen G; Hu X
J Hematol Oncol; 2022 Jun; 15(1):72. PubMed ID: 35659320
[TBL] [Abstract] [Full Text] [Related]
3. ACSL family: The regulatory mechanisms and therapeutic implications in cancer.
Quan J; Bode AM; Luo X
Eur J Pharmacol; 2021 Oct; 909():174397. PubMed ID: 34332918
[TBL] [Abstract] [Full Text] [Related]
4. Five-year survival outcomes of intensity-modulated radiotherapy with simultaneous integrated boost (IMRT-SIB) using forward IMRT or Tomotherapy for breast cancer.
Lee HH; Chen CH; Luo KH; Chuang HY; Huang CJ; Cheng YK; Chen F; Kuo SH; Huang MY
Sci Rep; 2020 Mar; 10(1):4342. PubMed ID: 32152428
[TBL] [Abstract] [Full Text] [Related]
5. Current detection rates and time-to-detection of all identifiable
Manchanda R; Blyuss O; Gaba F; Gordeev VS; Jacobs C; Burnell M; Gan C; Taylor R; Turnbull C; Legood R; Zaikin A; Antoniou AC; Menon U; Jacobs I
J Med Genet; 2018 Aug; 55(8):538-545. PubMed ID: 29622727
[TBL] [Abstract] [Full Text] [Related]
6. Association of long-chain acyl-coenzyme A synthetase 5 expression in human breast cancer by estrogen receptor status and its clinical significance.
Yen MC; Kan JY; Hsieh CJ; Kuo PL; Hou MF; Hsu YL
Oncol Rep; 2017 Jun; 37(6):3253-3260. PubMed ID: 28498416
[TBL] [Abstract] [Full Text] [Related]
7. 17β-estradiol-induced ACSL4 protein expression promotes an invasive phenotype in estrogen receptor positive mammary carcinoma cells.
Belkaid A; Ouellette RJ; Surette ME
Carcinogenesis; 2017 Apr; 38(4):402-410. PubMed ID: 28334272
[TBL] [Abstract] [Full Text] [Related]
8. Post-mastectomy radiation therapy and overall survival after neoadjuvant chemotherapy.
Kantor O; Pesce C; Singh P; Miller M; Tseng J; Wang CH; Winchester DJ; Yao K
J Surg Oncol; 2017 May; 115(6):668-676. PubMed ID: 28083910
[TBL] [Abstract] [Full Text] [Related]
9. Early Stage Triple-Negative breast cancer: Imaging and Clinical-Pathologic Factors Associated with Recurrence.
Bae MS; Moon HG; Han W; Noh DY; Ryu HS; Park IA; Chang JM; Cho N; Moon WK
Radiology; 2016 Feb; 278(2):356-64. PubMed ID: 26230976
[TBL] [Abstract] [Full Text] [Related]
10. Correlation between mammographic and sonographic findings and prognostic factors in patients with node-negative invasive breast cancer.
Shin HJ; Kim HH; Huh MO; Kim MJ; Yi A; Kim H; Son BH; Ahn SH
Br J Radiol; 2011 Jan; 84(997):19-30. PubMed ID: 20682592
[TBL] [Abstract] [Full Text] [Related]
11. Paget's disease of the nipple as local recurrence after breast-conservation treatment for early-stage breast cancer.
Plastaras JP; Harris EE; Solin LJ
Clin Breast Cancer; 2005 Oct; 6(4):349-53. PubMed ID: 16277886
[TBL] [Abstract] [Full Text] [Related]
12. Factors predicting for response, time to treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: a prospective Eastern Cooperative Oncology Group study.
Falkson G; Gelman R; Falkson CI; Glick J; Harris J
J Clin Oncol; 1991 Dec; 9(12):2153-61. PubMed ID: 1960558
[TBL] [Abstract] [Full Text] [Related]
